- Home
- PCRX vs WASH Comparison
PCRX vs WASH Comparison
Compare PCRX & WASH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCRX
- WASH
- Stock Information
- Founded
- PCRX 2006
- WASH 1800
- Country
- PCRX United States
- WASH United States
- Employees
- PCRX N/A
- WASH N/A
- Industry
- PCRX Biotechnology: Pharmaceutical Preparations
- WASH Major Banks
- Sector
- PCRX Health Care
- WASH Finance
- Exchange
- PCRX Nasdaq
- WASH Nasdaq
- Market Cap
- PCRX 1.2B
- WASH 542.9M
- IPO Year
- PCRX 2011
- WASH N/A
- Fundamental
- Price
- PCRX $22.90
- WASH $29.49
- Analyst Decision
- PCRX Buy
- WASH Buy
- Analyst Count
- PCRX 8
- WASH 4
- Target Price
- PCRX $28.38
- WASH $32.25
- AVG Volume (30 Days)
- PCRX 545.0K
- WASH 151.7K
- Earning Date
- PCRX 07-29-2025
- WASH 07-21-2025
- Dividend Yield
- PCRX N/A
- WASH 7.57%
- EPS Growth
- PCRX N/A
- WASH N/A
- EPS
- PCRX N/A
- WASH N/A
- Revenue
- PCRX $702,772,000.00
- WASH $110,088,000.00
- Revenue This Year
- PCRX $7.54
- WASH $57.46
- Revenue Next Year
- PCRX $10.78
- WASH $9.82
- P/E Ratio
- PCRX N/A
- WASH N/A
- Revenue Growth
- PCRX 3.08
- WASH N/A
- 52 Week Low
- PCRX $11.16
- WASH $24.95
- 52 Week High
- PCRX $27.64
- WASH $40.59
- Technical
- Relative Strength Index (RSI)
- PCRX 35.82
- WASH 61.71
- Support Level
- PCRX $22.82
- WASH $29.27
- Resistance Level
- PCRX $23.83
- WASH $30.15
- Average True Range (ATR)
- PCRX 0.74
- WASH 0.67
- MACD
- PCRX -0.02
- WASH 0.18
- Stochastic Oscillator
- PCRX 6.22
- WASH 79.94
About PCRX Pacira BioSciences Inc.
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.
About WASH Washington Trust Bancorp Inc.
Washington Trust Bancorp Inc through its subsidiaries offers banking and financial services to individuals and businesses. It offers a full range of financial services, including commercial banking, mortgage banking, personal banking, and wealth management and trust services, through its offices located in Rhode Island, Connecticut, and Massachusetts. It operates in two segments. The Commercial Banking segment includes lending activities, commercial loans, residential real estate loan deposit activities, and others. The Wealth Management Services segment consists of investment management, financial planning, personal trust, and estate services including services as trustee, personal representative, custodian and guardian, and settlement of decedents' estates.